Use of glycated haemoglobin blood test (HbA1c) screening for health promotion in surgical gynaecology oncology patients
Intended for healthcare professionals
Evidence and practice    

Use of glycated haemoglobin blood test (HbA1c) screening for health promotion in surgical gynaecology oncology patients

Margaret Ryan Macmillan gynaecology clinical nurse specialist, gynaecological oncology surgery, The Christie NHS Foundation Trust, Manchester, England
Laura Bradley Macmillan gynaecology clinical nurse specialist, The Christie NHS Foundation Trust, Manchester, England
Maria Kikayi Macmillan gynaecology clinical nurse specialist, The Christie NHS Foundation Trust, Manchester, England
Sarah Gallagher Macmillan gynaecology clinical nurse specialist, The Christie NHS Foundation Trust, Manchester, England
Jennifer Bartrop Gynaecology clinical nurse specialist, The Christie NHS Foundation Trust, Manchester, England

High body mass index (BMI) is a common risk factor for type 2 diabetes and many cancers, and the increasing prevalence of undiagnosed type 2 diabetes and high BMI affect patients’ outcomes. The surgical gynaecology clinical nurse specialist (CNS) team at The Christie NHS Foundation Trust identified that patients referred to their service might benefit from a glycated haemoglobin blood test (HbA1c) test as well as the other standard pre-operative blood tests.

The aim was to enable early identification of patients who required monitoring and intervention of their glucose levels in the preoperative period to reduce potential complications. Additionally, the results could be used to identify those who may be suitable for health promotion interventions.

This article discusses some of the negative effects of obesity and shares findings following the introduction of this screening, which show that 4% of patients had undiagnosed diabetes and 21% had impaired glucose regulation. It also describes the actions taken in response to these results, which included interventions such as lifestyle advice and monitoring.

Cancer Nursing Practice. doi: 10.7748/cnp.2019.e1592

Peer review

This article has been subject to external double-blind peer review and has been checked for plagiarism using automated software

Correspondence

margaret.ryan@christie.nhs.uk

Conflict of interest

None declared

Ryan M, Bradley L, Kikayi M et al (2019) Use of glycated haemoglobin blood test (HbA1c) screening for health promotion in surgical gynaecology oncology patients. Cancer Nursing Practice. doi: 10.7748/cnp.2019.e1592

Acknowledgement

The authors would like to acknowledge the guidance, advice and support provided by diabetes nurse specialist Louise Hopewell throughout the planning and implementation of the screening. They also greatly appreciate the input and support of the pre-op team

Published online: 17 September 2019

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or